nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2B6—Irinotecan—colon cancer	0.144	0.634	CbGbCtD
Perhexiline—Walking disability—Vincristine—colon cancer	0.0751	0.143	CcSEcCtD
Perhexiline—Walking disability—Capecitabine—colon cancer	0.0489	0.0934	CcSEcCtD
Perhexiline—CYP3A4—Irinotecan—colon cancer	0.0442	0.195	CbGbCtD
Perhexiline—Unsteadiness—Fluorouracil—colon cancer	0.0402	0.0767	CcSEcCtD
Perhexiline—CYP3A4—Vincristine—colon cancer	0.0386	0.17	CbGbCtD
Perhexiline—Cachexia—Capecitabine—colon cancer	0.0197	0.0377	CcSEcCtD
Perhexiline—Polyneuropathy—Capecitabine—colon cancer	0.0173	0.033	CcSEcCtD
Perhexiline—CPT1A—renal system—colon cancer	0.0169	0.113	CbGeAlD
Perhexiline—CPT2—renal system—colon cancer	0.016	0.107	CbGeAlD
Perhexiline—Balance disorder—Fluorouracil—colon cancer	0.0148	0.0282	CcSEcCtD
Perhexiline—CPT1A—digestive system—colon cancer	0.0138	0.0923	CbGeAlD
Perhexiline—CPT1A—vagina—colon cancer	0.0122	0.0815	CbGeAlD
Perhexiline—CPT2—bone marrow—colon cancer	0.0121	0.0807	CbGeAlD
Perhexiline—CPT2—vagina—colon cancer	0.0116	0.0773	CbGeAlD
Perhexiline—Balance disorder—Capecitabine—colon cancer	0.0103	0.0197	CcSEcCtD
Perhexiline—CPT1A—liver—colon cancer	0.0103	0.0688	CbGeAlD
Perhexiline—Hypertriglyceridaemia—Capecitabine—colon cancer	0.00982	0.0187	CcSEcCtD
Perhexiline—CPT2—liver—colon cancer	0.00979	0.0652	CbGeAlD
Perhexiline—Gait disturbance—Vincristine—colon cancer	0.00887	0.0169	CcSEcCtD
Perhexiline—Gait disturbance—Irinotecan—colon cancer	0.00863	0.0165	CcSEcCtD
Perhexiline—Blood triglycerides increased—Capecitabine—colon cancer	0.00861	0.0164	CcSEcCtD
Perhexiline—Torsade de pointes—Capecitabine—colon cancer	0.00804	0.0153	CcSEcCtD
Perhexiline—CPT1A—lymph node—colon cancer	0.00791	0.0527	CbGeAlD
Perhexiline—CPT2—lymph node—colon cancer	0.0075	0.05	CbGeAlD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	0.00701	0.0709	CbGpPWpGaD
Perhexiline—Ataxia—Vincristine—colon cancer	0.00591	0.0113	CcSEcCtD
Perhexiline—Gait disturbance—Capecitabine—colon cancer	0.00578	0.011	CcSEcCtD
Perhexiline—Muscular weakness—Vincristine—colon cancer	0.00554	0.0106	CcSEcCtD
Perhexiline—Ataxia—Fluorouracil—colon cancer	0.00551	0.0105	CcSEcCtD
Perhexiline—Muscular weakness—Fluorouracil—colon cancer	0.00517	0.00986	CcSEcCtD
Perhexiline—Weight decreased—Vincristine—colon cancer	0.00491	0.00937	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—HNF4A—colon cancer	0.00489	0.0495	CbGpPWpGaD
Perhexiline—Weight decreased—Irinotecan—colon cancer	0.00478	0.00913	CcSEcCtD
Perhexiline—CPT2—PPAR Alpha Pathway—CCND1—colon cancer	0.00476	0.0481	CbGpPWpGaD
Perhexiline—Neuropathy peripheral—Vincristine—colon cancer	0.00475	0.00905	CcSEcCtD
Perhexiline—Sweating—Vincristine—colon cancer	0.00464	0.00885	CcSEcCtD
Perhexiline—Sweating—Irinotecan—colon cancer	0.00452	0.00862	CcSEcCtD
Perhexiline—Neuropathy peripheral—Fluorouracil—colon cancer	0.00443	0.00844	CcSEcCtD
Perhexiline—CYP2B6—renal system—colon cancer	0.00417	0.0278	CbGeAlD
Perhexiline—Diplopia—Capecitabine—colon cancer	0.00409	0.00781	CcSEcCtD
Perhexiline—Flushing—Irinotecan—colon cancer	0.00393	0.00749	CcSEcCtD
Perhexiline—Ataxia—Capecitabine—colon cancer	0.00385	0.00734	CcSEcCtD
Perhexiline—CPT2—PPAR Alpha Pathway—MYC—colon cancer	0.00382	0.0386	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TOP1—colon cancer	0.00362	0.0366	CbGpPWpGaD
Perhexiline—Muscular weakness—Capecitabine—colon cancer	0.00361	0.00689	CcSEcCtD
Perhexiline—CYP2B6—lymphoid tissue—colon cancer	0.00346	0.0231	CbGeAlD
Perhexiline—CYP2B6—digestive system—colon cancer	0.00342	0.0228	CbGeAlD
Perhexiline—Syncope—Irinotecan—colon cancer	0.0033	0.0063	CcSEcCtD
Perhexiline—CPT1A—PPAR Alpha Pathway—CCND1—colon cancer	0.0033	0.0333	CbGpPWpGaD
Perhexiline—Convulsion—Vincristine—colon cancer	0.00328	0.00625	CcSEcCtD
Perhexiline—Loss of consciousness—Irinotecan—colon cancer	0.00324	0.00618	CcSEcCtD
Perhexiline—Weight decreased—Capecitabine—colon cancer	0.0032	0.00611	CcSEcCtD
Perhexiline—CYP3A4—renal system—colon cancer	0.00315	0.021	CbGeAlD
Perhexiline—CPT1A—RORA activates circadian gene expression—EP300—colon cancer	0.00313	0.0316	CbGpPWpGaD
Perhexiline—CYP2D6—renal system—colon cancer	0.0031	0.0206	CbGeAlD
Perhexiline—Neuropathy peripheral—Capecitabine—colon cancer	0.00309	0.0059	CcSEcCtD
Perhexiline—Convulsion—Fluorouracil—colon cancer	0.00306	0.00583	CcSEcCtD
Perhexiline—CYP2B6—vagina—colon cancer	0.00302	0.0201	CbGeAlD
Perhexiline—Hyperhidrosis—Vincristine—colon cancer	0.00298	0.00569	CcSEcCtD
Perhexiline—Shock—Irinotecan—colon cancer	0.00296	0.00564	CcSEcCtD
Perhexiline—Anorexia—Vincristine—colon cancer	0.00294	0.00561	CcSEcCtD
Perhexiline—Hyperhidrosis—Irinotecan—colon cancer	0.00291	0.00555	CcSEcCtD
Perhexiline—Anorexia—Irinotecan—colon cancer	0.00287	0.00547	CcSEcCtD
Perhexiline—Ataxia—Methotrexate—colon cancer	0.00287	0.00547	CcSEcCtD
Perhexiline—Hepatitis—Capecitabine—colon cancer	0.00283	0.0054	CcSEcCtD
Perhexiline—CYP2B6—Metapathway biotransformation—CHST4—colon cancer	0.00283	0.0286	CbGpPWpGaD
Perhexiline—CYP2D6—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00282	0.0285	CbGpPWpGaD
Perhexiline—Insomnia—Vincristine—colon cancer	0.00279	0.00533	CcSEcCtD
Perhexiline—Paraesthesia—Vincristine—colon cancer	0.00277	0.00529	CcSEcCtD
Perhexiline—Anorexia—Fluorouracil—colon cancer	0.00275	0.00524	CcSEcCtD
Perhexiline—Insomnia—Irinotecan—colon cancer	0.00272	0.00519	CcSEcCtD
Perhexiline—Paraesthesia—Irinotecan—colon cancer	0.0027	0.00515	CcSEcCtD
Perhexiline—Decreased appetite—Vincristine—colon cancer	0.00268	0.00512	CcSEcCtD
Perhexiline—Fatigue—Vincristine—colon cancer	0.00266	0.00508	CcSEcCtD
Perhexiline—CPT1A—PPAR Alpha Pathway—MYC—colon cancer	0.00264	0.0267	CbGpPWpGaD
Perhexiline—Flushing—Capecitabine—colon cancer	0.00263	0.00501	CcSEcCtD
Perhexiline—Decreased appetite—Irinotecan—colon cancer	0.00261	0.00499	CcSEcCtD
Perhexiline—Insomnia—Fluorouracil—colon cancer	0.0026	0.00497	CcSEcCtD
Perhexiline—Fatigue—Irinotecan—colon cancer	0.00259	0.00495	CcSEcCtD
Perhexiline—Paraesthesia—Fluorouracil—colon cancer	0.00259	0.00493	CcSEcCtD
Perhexiline—CYP3A4—digestive system—colon cancer	0.00258	0.0172	CbGeAlD
Perhexiline—CYP2B6—liver—colon cancer	0.00255	0.017	CbGeAlD
Perhexiline—CYP2D6—digestive system—colon cancer	0.00254	0.0169	CbGeAlD
Perhexiline—Gastrointestinal pain—Vincristine—colon cancer	0.00252	0.00482	CcSEcCtD
Perhexiline—Decreased appetite—Fluorouracil—colon cancer	0.0025	0.00478	CcSEcCtD
Perhexiline—Gastrointestinal pain—Irinotecan—colon cancer	0.00246	0.00469	CcSEcCtD
Perhexiline—Abdominal pain—Vincristine—colon cancer	0.00244	0.00466	CcSEcCtD
Perhexiline—Abdominal pain—Irinotecan—colon cancer	0.00238	0.00453	CcSEcCtD
Perhexiline—Tremor—Capecitabine—colon cancer	0.00231	0.00441	CcSEcCtD
Perhexiline—Urticaria—Fluorouracil—colon cancer	0.00229	0.00436	CcSEcCtD
Perhexiline—CPT2—Metabolism—CA7—colon cancer	0.00227	0.0229	CbGpPWpGaD
Perhexiline—Sweating—Methotrexate—colon cancer	0.00225	0.0043	CcSEcCtD
Perhexiline—Asthenia—Vincristine—colon cancer	0.00222	0.00423	CcSEcCtD
Perhexiline—Syncope—Capecitabine—colon cancer	0.00221	0.00422	CcSEcCtD
Perhexiline—Loss of consciousness—Capecitabine—colon cancer	0.00217	0.00413	CcSEcCtD
Perhexiline—Asthenia—Irinotecan—colon cancer	0.00216	0.00412	CcSEcCtD
Perhexiline—CPT2—PPARA activates gene expression—PPARG—colon cancer	0.00211	0.0213	CbGpPWpGaD
Perhexiline—Hepatitis—Methotrexate—colon cancer	0.00211	0.00402	CcSEcCtD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	0.00207	0.0209	CbGpPWpGaD
Perhexiline—Dizziness—Vincristine—colon cancer	0.00204	0.00389	CcSEcCtD
Perhexiline—Dizziness—Irinotecan—colon cancer	0.00199	0.00379	CcSEcCtD
Perhexiline—Shock—Capecitabine—colon cancer	0.00198	0.00378	CcSEcCtD
Perhexiline—CYP2D6—Metapathway biotransformation—CHST4—colon cancer	0.00197	0.0199	CbGpPWpGaD
Perhexiline—Vomiting—Vincristine—colon cancer	0.00196	0.00374	CcSEcCtD
Perhexiline—Rash—Vincristine—colon cancer	0.00195	0.00371	CcSEcCtD
Perhexiline—Hyperhidrosis—Capecitabine—colon cancer	0.00195	0.00371	CcSEcCtD
Perhexiline—Dermatitis—Vincristine—colon cancer	0.00194	0.00371	CcSEcCtD
Perhexiline—Headache—Vincristine—colon cancer	0.00193	0.00369	CcSEcCtD
Perhexiline—CYP3A4—liver—colon cancer	0.00192	0.0128	CbGeAlD
Perhexiline—Anorexia—Capecitabine—colon cancer	0.00192	0.00366	CcSEcCtD
Perhexiline—Vomiting—Irinotecan—colon cancer	0.00191	0.00365	CcSEcCtD
Perhexiline—Dizziness—Fluorouracil—colon cancer	0.0019	0.00363	CcSEcCtD
Perhexiline—Rash—Irinotecan—colon cancer	0.0019	0.00362	CcSEcCtD
Perhexiline—Dermatitis—Irinotecan—colon cancer	0.00189	0.00361	CcSEcCtD
Perhexiline—CYP2D6—liver—colon cancer	0.00189	0.0126	CbGeAlD
Perhexiline—Headache—Irinotecan—colon cancer	0.00188	0.00359	CcSEcCtD
Perhexiline—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00184	0.0186	CbGpPWpGaD
Perhexiline—Nausea—Vincristine—colon cancer	0.00183	0.0035	CcSEcCtD
Perhexiline—Vomiting—Fluorouracil—colon cancer	0.00183	0.00349	CcSEcCtD
Perhexiline—Insomnia—Capecitabine—colon cancer	0.00182	0.00347	CcSEcCtD
Perhexiline—Rash—Fluorouracil—colon cancer	0.00182	0.00346	CcSEcCtD
Perhexiline—Dermatitis—Fluorouracil—colon cancer	0.00181	0.00346	CcSEcCtD
Perhexiline—Paraesthesia—Capecitabine—colon cancer	0.00181	0.00345	CcSEcCtD
Perhexiline—Headache—Fluorouracil—colon cancer	0.0018	0.00344	CcSEcCtD
Perhexiline—Nausea—Irinotecan—colon cancer	0.00179	0.00341	CcSEcCtD
Perhexiline—Decreased appetite—Capecitabine—colon cancer	0.00175	0.00334	CcSEcCtD
Perhexiline—Fatigue—Capecitabine—colon cancer	0.00173	0.00331	CcSEcCtD
Perhexiline—Nausea—Fluorouracil—colon cancer	0.00171	0.00326	CcSEcCtD
Perhexiline—CPT1A—Circadian Clock—EP300—colon cancer	0.00167	0.0168	CbGpPWpGaD
Perhexiline—Gastrointestinal pain—Capecitabine—colon cancer	0.00165	0.00314	CcSEcCtD
Perhexiline—Urticaria—Capecitabine—colon cancer	0.0016	0.00305	CcSEcCtD
Perhexiline—Abdominal pain—Capecitabine—colon cancer	0.00159	0.00303	CcSEcCtD
Perhexiline—Convulsion—Methotrexate—colon cancer	0.00159	0.00303	CcSEcCtD
Perhexiline—CPT1A—Metabolism—CA7—colon cancer	0.00157	0.0159	CbGpPWpGaD
Perhexiline—CPT1A—PPARA activates gene expression—PPARG—colon cancer	0.00146	0.0148	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—CDKN1A—colon cancer	0.00146	0.0148	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Methotrexate—colon cancer	0.00145	0.00276	CcSEcCtD
Perhexiline—Asthenia—Capecitabine—colon cancer	0.00144	0.00275	CcSEcCtD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	0.00143	0.0145	CbGpPWpGaD
Perhexiline—Anorexia—Methotrexate—colon cancer	0.00143	0.00272	CcSEcCtD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.00142	0.0144	CbGpPWpGaD
Perhexiline—CPT2—PPARA activates gene expression—EP300—colon cancer	0.00138	0.014	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ODC1—colon cancer	0.00137	0.0139	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CHST5—colon cancer	0.00137	0.0139	CbGpPWpGaD
Perhexiline—Insomnia—Methotrexate—colon cancer	0.00135	0.00258	CcSEcCtD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.00135	0.0137	CbGpPWpGaD
Perhexiline—Paraesthesia—Methotrexate—colon cancer	0.00135	0.00257	CcSEcCtD
Perhexiline—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.00134	0.0135	CbGpPWpGaD
Perhexiline—Dizziness—Capecitabine—colon cancer	0.00133	0.00254	CcSEcCtD
Perhexiline—Decreased appetite—Methotrexate—colon cancer	0.0013	0.00248	CcSEcCtD
Perhexiline—CYP2B6—Metapathway biotransformation—CHST5—colon cancer	0.0013	0.0131	CbGpPWpGaD
Perhexiline—Fatigue—Methotrexate—colon cancer	0.00129	0.00246	CcSEcCtD
Perhexiline—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.00129	0.013	CbGpPWpGaD
Perhexiline—Vomiting—Capecitabine—colon cancer	0.00128	0.00244	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—TYMS—colon cancer	0.00128	0.0129	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00127	0.0129	CbGpPWpGaD
Perhexiline—Rash—Capecitabine—colon cancer	0.00127	0.00242	CcSEcCtD
Perhexiline—Dermatitis—Capecitabine—colon cancer	0.00127	0.00242	CcSEcCtD
Perhexiline—Headache—Capecitabine—colon cancer	0.00126	0.0024	CcSEcCtD
Perhexiline—Gastrointestinal pain—Methotrexate—colon cancer	0.00123	0.00234	CcSEcCtD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.0012	0.0122	CbGpPWpGaD
Perhexiline—Nausea—Capecitabine—colon cancer	0.0012	0.00228	CcSEcCtD
Perhexiline—Urticaria—Methotrexate—colon cancer	0.00119	0.00227	CcSEcCtD
Perhexiline—Abdominal pain—Methotrexate—colon cancer	0.00118	0.00226	CcSEcCtD
Perhexiline—Asthenia—Methotrexate—colon cancer	0.00107	0.00205	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—PIK3CA—colon cancer	0.00103	0.0104	CbGpPWpGaD
Perhexiline—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.00101	0.0102	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—TP53—colon cancer	0.000995	0.0101	CbGpPWpGaD
Perhexiline—Dizziness—Methotrexate—colon cancer	0.000991	0.00189	CcSEcCtD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.000987	0.00997	CbGpPWpGaD
Perhexiline—CPT1A—PPARA activates gene expression—EP300—colon cancer	0.000957	0.00967	CbGpPWpGaD
Perhexiline—Vomiting—Methotrexate—colon cancer	0.000952	0.00182	CcSEcCtD
Perhexiline—CPT1A—Metabolism—CHST5—colon cancer	0.000952	0.00962	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ODC1—colon cancer	0.000952	0.00962	CbGpPWpGaD
Perhexiline—Rash—Methotrexate—colon cancer	0.000945	0.0018	CcSEcCtD
Perhexiline—Dermatitis—Methotrexate—colon cancer	0.000944	0.0018	CcSEcCtD
Perhexiline—Headache—Methotrexate—colon cancer	0.000938	0.00179	CcSEcCtD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.000937	0.00947	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000931	0.00941	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—PPARG—colon cancer	0.000903	0.00913	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CHST5—colon cancer	0.000903	0.00912	CbGpPWpGaD
Perhexiline—Nausea—Methotrexate—colon cancer	0.00089	0.0017	CcSEcCtD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000886	0.00895	CbGpPWpGaD
Perhexiline—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000848	0.00857	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—AKT1—colon cancer	0.00084	0.00849	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000808	0.00816	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000779	0.00787	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—EP300—colon cancer	0.000724	0.00732	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000686	0.00693	CbGpPWpGaD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000646	0.00652	CbGpPWpGaD
Perhexiline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000607	0.00614	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—EP300—colon cancer	0.000591	0.00597	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.00059	0.00596	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000579	0.00585	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000567	0.00573	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000446	0.00451	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TP53—colon cancer	0.000423	0.00427	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000402	0.00407	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000393	0.00397	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CA7—colon cancer	0.000372	0.00376	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000371	0.00375	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ABCB1—colon cancer	0.000363	0.00367	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—TYMS—colon cancer	0.000356	0.0036	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000309	0.00312	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000274	0.00277	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CA7—colon cancer	0.000258	0.00261	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000257	0.0026	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PPARG—colon cancer	0.000252	0.00255	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ABCB1—colon cancer	0.000252	0.00254	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—TYMS—colon cancer	0.000247	0.0025	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CHST5—colon cancer	0.000225	0.00228	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ODC1—colon cancer	0.000225	0.00228	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTGS2—colon cancer	0.000199	0.00201	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.00019	0.00192	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PPARG—colon cancer	0.000175	0.00177	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CA7—colon cancer	0.000169	0.00171	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—EP300—colon cancer	0.000165	0.00167	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CHST5—colon cancer	0.000157	0.00158	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ODC1—colon cancer	0.000157	0.00158	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTGS2—colon cancer	0.000138	0.00139	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CA—colon cancer	0.000122	0.00123	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—EP300—colon cancer	0.000114	0.00116	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ODC1—colon cancer	0.000102	0.00103	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CHST5—colon cancer	0.000102	0.00103	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—AKT1—colon cancer	9.98e-05	0.00101	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CA—colon cancer	8.47e-05	0.000856	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—AKT1—colon cancer	6.92e-05	0.000699	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ABCB1—colon cancer	5.95e-05	0.000601	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—TYMS—colon cancer	5.85e-05	0.000591	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PPARG—colon cancer	4.14e-05	0.000418	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ABCB1—colon cancer	4.14e-05	0.000418	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—TYMS—colon cancer	4.06e-05	0.000411	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGS2—colon cancer	3.26e-05	0.000329	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PPARG—colon cancer	2.88e-05	0.000291	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—EP300—colon cancer	2.71e-05	0.000274	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ABCB1—colon cancer	2.7e-05	0.000273	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—TYMS—colon cancer	2.66e-05	0.000268	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGS2—colon cancer	2.26e-05	0.000229	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CA—colon cancer	2e-05	0.000203	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—EP300—colon cancer	1.88e-05	0.00019	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PPARG—colon cancer	1.88e-05	0.00019	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AKT1—colon cancer	1.64e-05	0.000165	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGS2—colon cancer	1.48e-05	0.00015	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CA—colon cancer	1.39e-05	0.000141	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—EP300—colon cancer	1.23e-05	0.000124	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AKT1—colon cancer	1.14e-05	0.000115	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CA—colon cancer	9.11e-06	9.2e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AKT1—colon cancer	7.44e-06	7.52e-05	CbGpPWpGaD
